Clinical Trials
4
Active:0
Completed:3
Trial Phases
2 Phases
Phase 1:2
Phase 2:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (50.0%)Phase 2
2 (50.0%)A Phase II, Placebo Controlled, Clinical Trial of Topical TolaSure Targeting Aggregated Mutant Keratin in Epidermolysis Bullosa Simplex
Phase 2
Recruiting
- Conditions
- Epidermolysis Bullosa Simplex
- Interventions
- Drug: 5% TolaSure Topical GelDrug: Topical Placebo Gel
- First Posted Date
- 2025-06-18
- Last Posted Date
- 2025-09-11
- Lead Sponsor
- BioMendics, LLC
- Target Recruit Count
- 40
- Registration Number
- NCT07027345
- Locations
- 🇺🇸
Stanford University School of Medicine, Dermatology Department, Palo Alto, California, United States
🇺🇸NU Dermatolgy CTU, Chicago, Illinois, United States
Safety and Efficacy of Topical TolaSure Targeting Aggregated Mutant Keratin in Severe Epidermolysis Bullosa Simplex
Phase 1
Completed
- Conditions
- Epidermolysis Bullosa Simplex
- Interventions
- Drug: Vehicle Topical Gel
- First Posted Date
- 2021-09-30
- Last Posted Date
- 2023-09-11
- Lead Sponsor
- BioMendics, LLC
- Target Recruit Count
- 6
- Registration Number
- NCT05062070
- Locations
- 🇺🇸
Stanford University School of Medicine, Dermatology Department, Redwood City, California, United States
Efficacy of Topical TolaSure on Acute Induced Wounds in Healthy Participants
Phase 2
Completed
- Conditions
- Wound Healing
- Interventions
- Drug: Topical Vehicle Gel
- First Posted Date
- 2019-09-12
- Last Posted Date
- 2021-06-24
- Lead Sponsor
- BioMendics, LLC
- Target Recruit Count
- 72
- Registration Number
- NCT04088357
- Locations
- 🇺🇸
University of Miami, Miami, Florida, United States
🇺🇸J&S Studies, College Station, Texas, United States
Safety and Efficacy of Topical TolaSure on Skin Punch Biopsies in Healthy Participants
- First Posted Date
- 2018-08-08
- Last Posted Date
- 2019-01-30
- Lead Sponsor
- BioMendics, LLC
- Target Recruit Count
- 22
- Registration Number
- NCT03620175
- Locations
- 🇺🇸
University of Miami, Miami, Florida, United States
News
No news found